<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>&lt;YOUR NAME HERE&gt; — HTBAA Fall 2026 :: alvaro-hernandez</title><link>https://pages.htgaa.org/2026b/alvaro-hernandez/index.html</link><description>About me Alvaro Hernandez Zelada, student at National University of San Marcos, interested in immunomodulators, immunology, cancer, nanoparticlesand protein denovo design.&#10;Contact info Homework, Labs, and Projects See the nav bar on the left to look through my work for How To Biomanufacture Almost Anything (Fall 2026)!</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026b/alvaro-hernandez/index.xml" rel="self" type="application/rss+xml"/><item><title>Week 1 HW: Final Project Ideas</title><link>https://pages.htgaa.org/2026b/alvaro-hernandez/week-01-hw-project-ideas/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/alvaro-hernandez/week-01-hw-project-ideas/index.html</guid><description>Biomanufacturing Homework 1 Folate-Targeted Lipid Nanoparticles Delivering CRISPR-Cas9 Against HPV16-Associated Cervical Cancer 1. What I Want to Make — and Why Product: Folate-receptor-targeted lipid nanoparticles (FA-LNPs) co-encapsulating Cas9 mRNA (modified with N1-methylpseudouridine) and two single-guide RNAs — sgRNA-E6 and sgRNA-E7 — directed against the HPV16 oncogenes responsible for cervical cancer. The final product is a sterile, injectable nanoparticle suspension of approximately 100 nm formulated in PBS with 10% sucrose as cryoprotectant.</description></item><item><title>Final Project</title><link>https://pages.htgaa.org/2026b/alvaro-hernandez/final-project/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/alvaro-hernandez/final-project/index.html</guid><description/></item></channel></rss>